We identified two immune system-specifically expressed genes, CCL4 and ITAGX, expressed by LSECs, as potential key players for the pathogenesis of disease development in NASH at the transcriptome level. Here, CCL4 is linked to metabolic dysfunction-associated steatohepatitis.